|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar
|
|
2
|
van den Berg A, Mols J and Han J:
RISC-target interaction: cleavage and translational suppression.
Biochim Biophys Acta. 1779:668–677. 2008.PubMed/NCBI
|
|
3
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kumar MS, Lu J, Mercer KL, Golub TR and
Jacks T: Impaired microRNA processing enhances cellular
transformation and tumorigenesis. Nat Genet. 39:673–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar
|
|
8
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lujambio A, Calin GA, Villanueva A, et al:
A microRNA DNA methylation signature for human cancer metastasis.
Proc Natl Acad Sci USA. 105:13556–13561. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma Y, Zhang P, Wang F, et al: miR-150 as a
potential biomarker associated with prognosis and therapeutic
outcome in colorectal cancer. Gut. 61:1447–1453. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Almeida MI, Nicoloso MS, Zeng L, et al:
Strand-specific miR-28-5p and miR-28-3p have distinct effects in
colorectal cancer cells. Gastroenterology. 142:886–896. e92012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pichler M, Ress AL, Winter E, et al:
MiR-200a regulates epithelial to mesenchymal transition-related
gene expression and determines prognosis in colorectal cancer
patients. Br J Cancer. 110:1614–1621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hwang WL, Jiang JK, Yang SH, et al:
MicroRNA-146a directs the symmetric division of Snail-dominant
colorectal cancer stem cells. Nat Cell Biol. 16:268–280. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang X, Zeng Z, Hou Y, et al: MicroRNA-92a
as a potential biomarker in diagnosis of colorectal cancer: a
systematic review and meta-analysis. PLoS One. 9:e887452014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Zhou Y, Feng X, et al: Low
expression of microRNA-126 is associated with poor prognosis in
colorectal cancer. Genes Chromosomes Cancer. 53:358–365. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao JJ, Yang J, Lin J, et al:
Identification of miRNAs associated with tumorigenesis of
retinoblastoma by miRNA microarray analysis. Childs Nerv Syst.
25:13–20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen YL, Jiang YG, Greenlee AR, Zhou LL
and Liu LH: MicroRNA expression profiles and miR-10a target in
anti-benzo[a] pyrene-7, 8-diol-9, 10-epoxide-transformed human
16HBE cells. Biomed Environ Sci. 22:14–21. 2009.PubMed/NCBI
|
|
19
|
Liu Y, Lai L, Chen Q, et al: MicroRNA-494
is required for the accumulation and functions of tumor-expanded
myeloid-derived suppressor cells via targeting of PTEN. J Immunol.
188:5500–5510. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kwak SY, Yang JS, Kim BY, Bae IH and Han
YH: Ionizing radiation-inducible miR-494 promotes glioma cell
invasion through EGFR stabilization by targeting p190B rhoGAP.
Biochim Biophys Acta. 1843:508–516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamanaka S, Campbell NR, An F, et al:
Coordinated effects of microRNA-494 induce G2/M arrest
in human cholangiocarcinoma. Cell Cycle. 11:2729–2738. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Olaru AV, Ghiaur G, Yamanaka S, et al:
MicroRNA downregulated in human cholangiocarcinoma control cell
cycle through multiple targets involved in the G1/S checkpoint.
Hepatology. 54:2089–2098. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Luo F, Li Q, et al: Identification
of new aberrantly expressed miRNAs in intestinal-type gastric
cancer and its clinical significance. Oncol Rep. 26:1431–1439.
2011.PubMed/NCBI
|
|
24
|
Leibovitz A, Stinson JC, McCombs WB 3rd,
McCoy CE, Mazur KC and Mabry ND: Classification of human colorectal
adenocarcinoma cell lines. Cancer Res. 36:4562–4569.
1976.PubMed/NCBI
|
|
25
|
Sawai H, Yasuda A, Ochi N, et al: Loss of
PTEN expression is associated with colorectal cancer liver
metastasis and poor patient survival. BMC Gastroenterol. 8:562008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bowen KA, Doan HQ, Zhou BP, et al: PTEN
loss induces epithelial-mesenchymal transition in human colon
cancer cells. Anticancer Res. 29:4439–4449. 2009.PubMed/NCBI
|
|
27
|
Liu L, Jiang Y, Zhang H, Greenlee AR and
Han Z: Overexpressed miR-494 down-regulates PTEN gene expression in
cells transformed by anti-benzo(a)pyrene-trans-7,8-dihydrodiol-
9,10-epoxide. Life Sci. 86:192–198. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ohdaira H, Sekiguchi M, Miyata K and
Yoshida K: Micro-RNA-494 suppresses cell proliferation and induces
senescence in A549 lung cancer cells. Cell Prolif. 45:32–38. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lim L, Balakrishnan A, Huskey N, et al:
MicroRNA-494 within an oncogenic microRNA megacluster regulates
G1/S transition in liver tumorigenesis through suppression of
mutated in colorectal cancer. Hepatology. 59:202–215. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Romano G, Acunzo M, Garofalo M, et al:
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced
apoptosis in non-small-cell lung cancer through BIM
down-regulation. Proc Natl Acad Sci USA. 109:16570–16575. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Molinari F and Frattini M: Functions and
regulation of the PTEN gene in colorectal cancer. Front Oncol.
3:3262014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sansal I and Sellers WR: The biology and
clinical relevance of the PTEN tumor suppressor pathway. J Clin
Oncol. 22:2954–2963. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Castellino RC and Durden DL: Mechanisms of
disease: the PI3K-Akt-PTEN signaling node - an intercept point for
the control of angiogenesis in brain tumors. Nat Clin Pract Neurol.
3:682–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grille SJ, Bellacosa A, Upson J, et al:
The protein kinase Akt induces epithelial mesenchymal transition
and promotes enhanced motility and invasiveness of squamous cell
carcinoma lines. Cancer Res. 63:2172–2178. 2003.
|
|
35
|
Vogt PK, Gymnopoulos M and Hart JR: PI
3-kinase and cancer: changing accents. Curr Opin Genet Dev.
19:12–17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang S and Yu D: PI(3)king apart PTEN’s
role in cancer. Clin Cancer Res. 16:4325–4330. 2010.PubMed/NCBI
|
|
37
|
Song MS, Salmena L and Pandolfi PP: The
functions and regulation of the PTEN tumour suppressor. Nat Rev Mol
Cell Biol. 13:283–296. 2012.PubMed/NCBI
|
|
38
|
Stewart AL, Mhashilkar AM, Yang XH, et al:
PI3 kinase blockade by Ad-PTEN inhibits invasion and induces
apoptosis in RGP and metastatic melanoma cells. Mol Med. 8:451–461.
2002.PubMed/NCBI
|
|
39
|
Tamura M, Gu J, Matsumoto K, Aota S,
Parsons R and Yamada KM: Inhibition of cell migration, spreading,
and focal adhesions by tumor suppressor PTEN. Science.
280:1614–1617. 1998. View Article : Google Scholar : PubMed/NCBI
|
